ZYME Competitors & Alternatives
Compare Zymeworks Inc. Common Stock with similar stocks in the same industry
Biotechnology
ZYME
Main Stock$28.44
Tradestie Score
35
Market Cap
$1.28B
Revenue Growth
-0.9%
Analyst Upside
+44.9%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$52.43
|
$2.21B | - | 75 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$18.66
|
$2.18B | - | 68 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$12.55
|
$2.08B | - | 59 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$18.18
|
$2.02B | - | 54 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.16
|
$2.01B | - | 46 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$31.31
|
$1.97B | - | 62 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$6.61
|
$1.92B | - | 62 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$65.57
|
$1.92B | - | 57 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$39.69
|
$1.90B | 26.3 | 52 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$29.05
|
$1.84B | - | 65 | Compare |
More ZYME Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry